JP2016539172A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539172A5
JP2016539172A5 JP2016536849A JP2016536849A JP2016539172A5 JP 2016539172 A5 JP2016539172 A5 JP 2016539172A5 JP 2016536849 A JP2016536849 A JP 2016536849A JP 2016536849 A JP2016536849 A JP 2016536849A JP 2016539172 A5 JP2016539172 A5 JP 2016539172A5
Authority
JP
Japan
Prior art keywords
ganglioside
carbohydrate
cancer
pharmaceutical composition
multimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016536849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539172A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2014/051165 external-priority patent/WO2015081438A1/en
Publication of JP2016539172A publication Critical patent/JP2016539172A/ja
Publication of JP2016539172A5 publication Critical patent/JP2016539172A5/ja
Pending legal-status Critical Current

Links

JP2016536849A 2013-12-06 2014-12-04 癌標的化及び抗体作製のための抗ガングリオシド化合物 Pending JP2016539172A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361912684P 2013-12-06 2013-12-06
US61/912,684 2013-12-06
PCT/CA2014/051165 WO2015081438A1 (en) 2013-12-06 2014-12-04 Anti-ganglioside compound for targeting cancer and generating antibodies

Publications (2)

Publication Number Publication Date
JP2016539172A JP2016539172A (ja) 2016-12-15
JP2016539172A5 true JP2016539172A5 (https=) 2017-03-09

Family

ID=53272688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016536849A Pending JP2016539172A (ja) 2013-12-06 2014-12-04 癌標的化及び抗体作製のための抗ガングリオシド化合物

Country Status (7)

Country Link
US (1) US10363305B2 (https=)
EP (2) EP3957327A1 (https=)
JP (1) JP2016539172A (https=)
CN (1) CN106414472A (https=)
CA (1) CA2968995A1 (https=)
ES (1) ES2904533T3 (https=)
WO (1) WO2015081438A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018112669A1 (en) * 2016-12-23 2018-06-28 Realist Pharma, Inc. Ganglioside carbohydrate structures and uses thereof
WO2022076364A1 (en) * 2020-10-05 2022-04-14 Aoa Dx Compositions and methods for cancer diagnosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE372783T1 (de) * 1993-01-22 2007-09-15 Sloan Kettering Inst Cancer Gangliosid-klh-konjugatimpfstoffe mit qs-21 zur verzögerung des wiederauftretens eines melanoms
WO2002062810A2 (en) 2000-11-29 2002-08-15 Bracco International B.V. Linkable sialyl lewis x analogs
EP1458242A4 (en) 2001-07-06 2006-06-07 Sloan Kettering Inst Cancer COMPREHENSIVE CONJUGATED VACCINE AGAINST CANCER
JP2003073397A (ja) 2001-08-30 2003-03-12 Wakamoto Pharmaceut Co Ltd 合成ムチン
AU2003275954A1 (en) * 2002-11-08 2004-06-07 Danmarks Fodevareforskning Preparation of chemically well-defined carbohydrate dendrimer conjugates
JP4742339B2 (ja) 2005-06-14 2011-08-10 独立行政法人産業技術総合研究所 シアル酸含有3糖化合物、それを用いるサーズウイルスまたはサーズスパイク蛋白質の検出
JP5130598B2 (ja) * 2005-09-02 2013-01-30 静岡県公立大学法人 ウイルスレセプター糖鎖認識特異性の判別方法
JP2008031156A (ja) 2006-07-07 2008-02-14 National Univ Corp Shizuoka Univ 抗ウイルス剤

Similar Documents

Publication Publication Date Title
JP2017518302A5 (https=)
JP2016506916A5 (https=)
CY1122840T1 (el) Ανθρωποποιημενα ή χιμαιρικα αντισωματα cd3
JP2016515561A5 (https=)
JP2018502885A5 (https=)
EA201692530A1 (ru) Цитотоксические пептиды и их конъюгаты
JP2016512425A5 (https=)
JP2017525730A5 (https=)
JP2016503799A5 (https=)
JP2014176384A5 (https=)
JP2013519675A5 (https=)
JP2016040288A5 (https=)
EA201792407A2 (ru) Композиции, содержащие буфер, составы вакцин, которые содержат композиции, содержащие буфер, и пути их применения
JP2009536191A5 (https=)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2015512432A5 (https=)
EA201590427A1 (ru) Нелинейные сахаридные конъюгаты
JP2015509075A5 (https=)
MX394367B (es) Moléculas tipo esfingolípidos sintéticas, fármacos, métodos de su síntesis y usos de los mismos.
Westwood et al. Routes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in mice
JP2016539172A5 (https=)
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
SG194735A1 (en) Compositions and methods for treating cancer
WO2015009731A3 (en) Azacyclic constrained analogs of fty720
JP2016503026A5 (https=)